PRESS RELEASE published on 09/02/2025 at 13:00, 6 months 25 days ago Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF published on 08/27/2025 at 19:29, 6 months 30 days ago Les vaccins Moderna contre la COVID-19 mis à jour approuvés par la FDA américaine Approbation De La FDA Moderne Vaccin Contre Le Covid-19 Variante Du SRAS-CoV-2 Spikevax Et MNEXSPIKE
BRIEF published on 08/27/2025 at 19:29, 6 months 30 days ago Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE published on 08/27/2025 at 19:24, 6 months 30 days ago Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF published on 08/22/2025 at 15:30, 7 months 4 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
BRIEF published on 08/22/2025 at 15:30, 7 months 4 days ago Moderna reçoit l'approbation de Santé Canada pour son vaccin contre la COVID-19 mis à jour Moderne Vaccin Contre Le Covid-19 Fabrication Canadienne Approbation De Santé Canada Leadership En Bioproduction
PRESS RELEASE published on 08/22/2025 at 15:25, 7 months 4 days ago Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF published on 08/21/2025 at 13:05, 7 months 6 days ago Moderna participera aux principales conférences de septembre 2025 Conférences D'investisseurs Moderne Webcast En Direct Médecine À Base D'ARNm Présentation Des Soins De Santé
BRIEF published on 08/21/2025 at 13:05, 7 months 6 days ago Moderna to Participate in Major September 2025 Conferences Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE published on 08/21/2025 at 13:00, 7 months 6 days ago Moderna to Present at Upcoming Conferences in September 2025 Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
Published on 03/27/2026 at 12:30, 1 hour 45 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 2 hours 15 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 3 hours 15 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 4 hours 45 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 13:30, 45 minutes ago Weiqiao Pioneering Group Adds Sixth National 'Green Factory'
Published on 03/27/2026 at 13:30, 45 minutes ago Weiqiao Chuangye : le groupe compte désormais six sites labellisés « usine verte » nationale
Published on 03/27/2026 at 13:00, 1 hour 15 minutes ago NR21: Mise à disposition du Rapport financier annuel 2025
Published on 03/27/2026 at 11:45, 2 hours 30 minutes ago Second National Showcase of Outstanding Works from China’s Rare Operatic Genres Held
Published on 03/27/2026 at 07:00, 7 hours 15 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 19 hours 58 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 19 hours 58 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 20 hours 15 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
